2022 Volume 48 - Canada Communicable Disease Report (CCDR)

ISSN: 1481-8531

2022 Volume 48

CCDR: Volume 48-11/12, November/December 2022: Antimicrobial Use and Stewardship

• Short-course antibiotic therapy: The next frontier in antimicrobial stewardship
• Moving the needle on dental antibiotic overuse in Canada post COVID-19
• The Canadian Nosocomial Infection Surveillance Program: Keeping an eye on antimicrobial resistance in Canadian hospitals since 1995
• Antibiotic prescribing and antimicrobial stewardship in long-term care facilities: Past interventions and implementation challenges
• Overview of Canada's Antimicrobial Resistance Network (AMRNet): A data-driven One Health approach to antimicrobial resistance surveillance
• Hospital and related resource costs associated with antimicrobial-resistant infections in Canada, 2019
• National Hepatitis C estimates: Incidence, prevalence, undiagnosed proportion and treatment, Canada, 2019
• Understanding Canadians' knowledge, attitudes and practices related to antimicrobial resistance and antibiotic use: Results from public opinion research
• Prevalence of antimicrobial-resistant organisms in smaller Canadian hospitals: Community, Rural, and Northern Acute Care Point Prevalence (CNAPP-19) Survey, 2019
• Antimicrobial susceptibilities of Neisseria gonorrhoeae in Canada, 2020
• Summary of the National Advisory Committee on Immunization (NACI) Rapid Response: Updated interim guidance on Imvamune in the context of ongoing monkeypox outbreaks
• Infectious syphilis and congenital syphilis in Canada, 2021
• Response to letter: "Circular logic and flawed modelling compromises non-pharmaceutical intervention paper's conclusions"
• Is there protective immunity after an Omicron infection?
• Thank you to the CCDR peer reviewers of 2022

CCDR Volume 48-10, October 2022: Equity, Diversity and Inclusion in Public Health

• Vaccination of children in marginalized neighbourhoods: Equity and diversity challenges with COVID-19 vaccination campaigns
• Summary of an environmental scan of HIV and Hepatitis C programs, projects and initiatives in Saskatchewan
• A cross-sectional investigation of HIV prevalence and risk factors among African, Caribbean and Black people in Ontario: The A/C Study
• Effectiveness of non-pharmaceutical interventions to reduce SARS-CoV-2 transmission in Canada and their association with COVID-19 hospitalization rates
• Modelling COVID-19 transmission using IDSIM, an epidemiological-modelling desktop app with multi-level immunization capabilities
• Demographic patterns of exposure and transmission for a rural Canadian community outbreak of COVID-19, 2020
• National Influenza Annual Report, Canada, 2021–2022: A brief, late influenza epidemic
• Surveillance of laboratory exposures to human pathogens and toxins, Canada, 2021
• Circular logic and flawed modelling compromises non-pharmaceutical intervention article’s conclusions
• Response from the Editor-in-Chief

CCDR Volume 48-9, September 2022: Invasive Diseases Surveillance in Canada

• Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2022–2023
• Summary of the National Advisory Committee on Immunization (NACI) Supplemental Statement on Recombinant Influenza Vaccines
• Evaluation of influenza case definitions for use in real-world evidence research
• Invasive pneumococcal disease surveillance in Canada, 2020
• Invasive group A streptococcal disease surveillance in Canada, 2020
• In-person learning low risk for COVID-19 acquisition: Findings from a population-based analysis of the 2020–2021 school year in Saskatchewan, Canada

CCDR Volume 48-7/8, July/August 2022: Healthcare-Associated Infections & Antimicrobial Resistance

• Counterfactuals of effects of vaccination and public health measures on COVID-19 cases in Canada: What could have happened?
• Laboratory-acquired infections in Canada from 2016 to 2021
• Healthcare-associated infections and antimicrobial resistance in Canadian acute care hospitals, 2016–2020
• Device and surgical procedure-related infections in Canadian acute care hospitals from 2011 to 2020
• National healthcare-associated infections surveillance programs: A scoping review
• Multivariate analyses of risk factors associated with laboratory exposure incidents
• Compliance with COVID-19 preventive measures is high among university-level students in Québec, Canada
• Summary of the National Advisory Committee on Immunization (NACI) statement update on the recommended use of palivizumab to reduce complications of respiratory syncytial virus infection in infants
• Summary of the National Advisory Committee on Immunization (NACI) Rapid Response—Interim guidance on the use of Imvamune in the context of monkeypox outbreaks in Canada
• What do people think about COVID-19 booster doses?

CCDR Volume 48-6, June 2022: Vector-Borne Infections–Part 2: Wildlife & Companion Animals

• Rabies through an imported dog, Ontario, 2021
• SARS-CoV-2 wildlife surveillance in Ontario and Québec
• SARS-CoV-2 wildlife surveillance surrounding mink farms in British Columbia, Canada
• One Health response to SARS-CoV-2-associated risk from mink farming in British Columbia, Canada, October 2020 to October 2021
• SARS-CoV-2 in mink farms in British Columbia, Canada: A report of two outbreaks in 2020–2021
• A multi-provincial Salmonella Typhimurium outbreak in Canada associated with exposure to pet hedgehogs, 2017–2020
• Monkeypox brief, June 2022

CCDR Volume 48-5, May 2022: Vector-Borne Infections–Part 1: Ticks & Mosquitoes

• An overview of the National West Nile Virus Surveillance System in Canada: A One Health approach
• Identification of an unusual cluster of human granulocytic anaplasmosis in the Estrie region, Québec, Canada in 2021
• A meteorological-based forecasting model for predicting minimal infection rates in Culex pipiens-restuans complex using Québec's West Nile virus integrated surveillance system
• Surveillance for Ixodes scapularis and Ixodes pacificus ticks and their associated pathogens in Canada, 2019
• Surveillance for Lyme disease in Canada, 2009–2019
• Epidemiology of invasive meningococcal disease in Canada, 2012–2019
• Lyme disease surveillance report, 2019
• Mosquito-borne diseases surveillance report, 2019

CCDR Volume 48-4, April 2022: First Nations Health

• Supporting health equity for First Nations, Inuit and Métis peoples
• Canadian blood suppliers: An expanding role in public health surveillance?
• The need for linked genomic surveillance of SARS-CoV-2
• Multijurisdictional outbreak of COVID-19 associated with a wake/funeral event in a northern Saskatchewan First Nations community
• Summary findings from Tracks Surveys implemented by First Nations in Saskatchewan and Alberta, Canada, 2018–2020
• Antibiotic prescribing for respiratory tract infection across a national primary care network in 2019
• Impact of the first vaccine dose on COVID-19 and its complications in long-term care facilities and private residences for seniors in Québec, Canada
• Regional differences in access to direct-acting antiviral treatments for hepatitis C across Ontario: A cross-sectional study
• Are there clinically significant interactions between COVID-19 vaccination and post-COVID-19 condition (long COVID)?

CCDR Volume 48-2/3, February/March 2022: Syphilis Resurgence in Canada

• Rising syphilis rates in Canada, 2011–2020
• Outcomes of infectious syphilis in pregnant patients and maternal factors associated with congenital syphilis diagnosis, Alberta, 2017–2020
• Characterizing female infectious syphilis cases in British Columbia to identify opportunities for optimization of care
• Syphilis in Ottawa: An evolving epidemic
• Laboratory evaluation of two point-of-care test kits for the identification of infectious syphilis
• Congenital syphilis re-emergence in Winnipeg, Manitoba
• A descriptive study of syphilis testing in Manitoba, Canada, 2015–2019
• Lessons from management of syphilis in Nunavut, Canada, 2012–2020
• Exploring management of antenatally diagnosed fetal syphilis infection
• Delayed diagnosis of maternal and congenital syphilis: An unrecognized epidemic?

CCDR Volume 48-01, January 2022: COVID-19 Mortality and Social Inequalities

• Canadian Public Health Laboratory Network Statement on Point-of-Care Serology Testing in COVID-19
• Divergences between healthcare-associated infection administrative data and active surveillance data in Canada
• The Yukon's experience with COVID-19: Travel restrictions, variants and spread among the unvaccinated
• Epidemiological analysis of the emergence and disappearance of the SARS-CoV-2 Kappa variant within a region of British Columbia, Canada
• Social inequalities in COVID-19 mortality by area and individual-level characteristics in Canada, January to July/August 2020: Results from two national data integrations
• National FluWatch mid-season report, 2021–2022: Sporadic influenza activity returns
• Escherichia coli O103 outbreak associated with minced celery among hospitalized individuals in Victoria, British Columbia, 2021
• Thank you to the CCDR peer reviewers of 2021